Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2003-11-26 AGM Information
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Chairman's AGM Address to Shareholders 4 pages ?Kb
AGM Information Classification · 95% confidence The document is titled 'CHAIRMAN'S ADDRESS' and is presented at the Annual General Meeting (AGM) held on 27 November 2003. It contains a detailed address from the Chairman discussing the company's achievements over the past 12 months, management changes, scientific progress, financial position, and future objectives. The content is typical of a speech or presentation given at an AGM rather than a full annual report or financial statement. There is no detailed financial data or comprehensive financial statements included, which would be expected in an Annual Report (10-K). The document also references the 2003 Annual Report but does not itself contain the report. Given the nature of the content and the context, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM.
2003-11-26 English
AGM Shareholder Presentation 10 pages ?Kb
AGM Information Classification · 95% confidence The document is titled 'Annual General Meeting Shareholder Presentation' and dated 27 November 2003. The content consists of slides discussing business strategy, product focus, market positioning, regulatory environment, and collaborations. There are no financial statements or detailed financial data presented. The document is clearly a presentation given at an AGM, intended for shareholders and investors to communicate company strategy and updates. It is not an annual report, earnings release, or any other formal regulatory filing. Therefore, the document fits the category of AGM Information (AGM-R). The document length is 2262 characters, which is consistent with a presentation rather than a full report.
2003-11-26 English
Results of Meeting/Appendix 3B-Issue of Performance Options 12 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and details the voting results of resolutions passed at the AGM held on 27 November 2003. It includes specific voting outcomes on director re-election, share issue ratification, granting of performance options, and reduction of share capital. Additionally, it references an Appendix 3B related to new issue announcements and securities issued, which is typical for disclosures following shareholder approval at an AGM. The content is focused on the announcement of voting results and related corporate actions approved at the AGM, rather than the full AGM materials or the full annual report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement but a full disclosure of voting results, supporting a high confidence classification.
2003-11-26 English
Awarded Federal Grant to Take Product to Market 2 pages ?Kb
Regulatory Filings
2003-11-20 English
Annual Report 56 pages ?Kb
Regulatory Filings
2003-10-26 English
Notice of Annual General Meeting 15 pages ?Kb
Regulatory Filings
2003-10-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.